Published in Ann N Y Acad Sci on January 01, 1990
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun (1998) 2.71
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest (1992) 1.20
A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest (1998) 1.13
Retinoid and TGF-β families: crosstalk in development, neoplasia, immunity, and tissue repair. Semin Nephrol (2012) 0.85
Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. J Clin Invest (1992) 0.84
Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound. Am J Pathol (2001) 0.81
Inhibitory RNA molecules in immunotherapy for cancer. Methods Mol Biol (2010) 0.77
Transforming growth factor-beta 1 (TGF-beta1) expression in ovine lentivirus-induced lymphoid interstitial pneumonia. Clin Exp Immunol (1998) 0.77
Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis. Gut (2003) 0.76
Inhibition of immune reactions in vivo by liposome associated transforming growth factor (TGF) type beta 1. Clin Exp Immunol (1991) 0.76
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc (1991) 0.75
Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell (1978) 11.17
Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (1983) 10.64
Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc Natl Acad Sci U S A (1979) 7.55
The primary structure and genetic organization of the bovine papillomavirus type 1 genome. Nature (1982) 7.24
Expression of human immune interferon cDNA in E. coli and monkey cells. Nature (1982) 6.55
Comparative biochemical properties of normal and activated human ras p21 protein. Nature (1984) 6.50
Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature (1984) 6.21
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90
Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc Natl Acad Sci U S A (1983) 5.46
Initiation of translation at internal AUG codons in mammalian cells. Nature (1984) 5.34
Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product. Nature (1980) 5.22
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc Natl Acad Sci U S A (1980) 4.99
Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature (1983) 4.15
Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06
Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src). Proc Natl Acad Sci U S A (1981) 4.04
The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J Biol Chem (1980) 3.95
Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature (1984) 3.86
Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids. Mol Cell Biol (1983) 3.63
Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus. Nature (1983) 3.42
The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell (1983) 3.21
Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell (1994) 2.88
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Retracted Preliminary report: effects of interleukin-1 on platelet counts. Lancet (1990) 2.25
Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol (1986) 2.24
Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science (1993) 2.17
Receptor-mediated internalization of Pseudomonas toxin by mouse fibroblasts. Cell (1980) 2.17
Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus. Virology (1981) 2.16
Identification of the type I trimethoprim-resistant dihydrofolate reductase specified by the Escherichia coli R-plasmid R483: comparison with procaryotic and eucaryotic dihydrofolate reductases. J Bacteriol (1983) 2.15
A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Mol Cell Biol (1985) 2.12
The structure and protein kinase activity of proteins encoded by nonconditional mutants and back mutants in the sec gene of avian sarcoma virus. Virology (1981) 2.06
Inhibitory and stimulatory G proteins of adenylate cyclase: cDNA and amino acid sequences of the alpha chains. Proc Natl Acad Sci U S A (1986) 2.03
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest (1990) 2.02
Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Cell (1983) 1.98
The oncogenic activation of human p21ras by a novel mechanism. Science (1986) 1.89
Origin and function of avian retrovirus transforming genes. Cold Spring Harb Symp Quant Biol (1980) 1.89
Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J Neurosci (1995) 1.85
Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells. Mol Cell Biol (1983) 1.85
Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82
The epidemiology of serious eye injuries from the United States Eye Injury Registry. Graefes Arch Clin Exp Ophthalmol (2000) 1.81
Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors (1990) 1.72
Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol (1999) 1.72
The group C adenovirus tumor antigens: identification in infected and transformed cells and a peptide map analysis. Cell (1977) 1.65
The product of the avian erythroblastosis virus erbB locus is a glycoprotein. Cell (1983) 1.62
Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector. DNA (1982) 1.62
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit (2001) 1.53
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex. Growth Factors (1989) 1.51
Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol (1988) 1.51
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet (1991) 1.49
Signal transduction by the platelet integrin alpha IIb beta 3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells. Mol Biol Cell (1992) 1.47
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer. Br J Cancer (2002) 1.45
The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg (1987) 1.44
Bacterial expression of an enzymatically active protein encoded by RSV src gene. Nature (1982) 1.44
Newer immunosuppressive drugs: a review. J Am Soc Nephrol (1999) 1.43
Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J Clin Invest (1993) 1.42
Expression of hepatitis B virus surface antigen in yeast. Nucleic Acids Res (1983) 1.39
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol (1987) 1.34
Evolving techniques in the treatment of macular detachment caused by optic nerve pits. Ophthalmology (1988) 1.32
A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature (1988) 1.32
AnkB, a periplasmic ankyrin-like protein in Pseudomonas aeruginosa, is required for optimal catalase B (KatB) activity and resistance to hydrogen peroxide. J Bacteriol (2000) 1.31
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol (1996) 1.31
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation (1999) 1.30
Expression of the H-ras proto-oncogene is controlled by alternative splicing. Cell (1989) 1.29
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med (1990) 1.28
Suppression of mammalian 5' splice-site defects by U1 small nuclear RNAs from a distance. Proc Natl Acad Sci U S A (1994) 1.23
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation (1993) 1.22
In vivo and in vitro phosphorylation of the adenovirus type 5 single strand-specific DNA-binding protein. Virology (1977) 1.20
Expression of normal and activated human Ha-ras cDNAs in Saccharomyces cerevisiae. Mol Cell Biol (1985) 1.19
Globe perforation from peribulbar injection. Arch Ophthalmol (1987) 1.17
Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood (1991) 1.17
The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Mol Cell Biol (1988) 1.16
Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step. Infect Immun (1983) 1.15
Adenovirus VAI-RNA regulates gene expression by controlling stability of ribosome-bound RNAs. EMBO J (1989) 1.14
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg (1996) 1.10
Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes. Mol Cell Biol (1986) 1.09
Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum. J Immunol (1999) 1.07
Localization of ClC-2 Cl- channels in rabbit gastric mucosa. Am J Physiol Cell Physiol (2001) 1.06
The role of respiratory epithelium in a rat model of obliterative airway disease. Transplantation (2000) 1.06
Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD. Transplant Proc (2001) 1.06
Recurrent varicose veins: a radiological approach to investigation. Clin Radiol (1984) 1.06
Vitrectomy in asteroid hyalosis. Retina (1990) 1.05
Dental caries experience of disabled children and young adults in Kuwait. Community Dent Health (2001) 1.04
High-level expression of c-H-ras1 fails to fully transform rat-1 cells. Mol Cell Biol (1988) 1.03
Whole body lipid and energy metabolism in the cancer patient. Metabolism (1987) 1.03
Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res (1993) 1.02
Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proc Natl Acad Sci U S A (1987) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Technics for fiberoptic laryngoscopy in anesthesia. Anesth Analg (1974) 1.00
Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem (1989) 1.00
Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol (2001) 1.00
Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell. Infect Immun (1986) 1.00
Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim Biophys Acta (1988) 0.99
Hormonal and metabolic response to recombinant human tumor necrosis factor in rat: in vitro and in vivo. Am J Physiol (1988) 0.99
U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing. Mol Cell Biol (1993) 0.98
Chimeric proteins define variable and essential regions of Ha-ras-encoded protein. Proc Natl Acad Sci U S A (1988) 0.98